间质干细胞的免疫抑制能力：胰岛移植中的治疗意义。
Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.
机构信息
Transplantation Research Immunology Group, Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
出版信息
Transplantation. 2010 Feb 15;89(3):270-3. doi: 10.1097/TP.0b013e3181c6ffbe.
Abstract
Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses and offer therapeutic potential for achieving transplantation tolerance. This review will discuss the impacts of MSCs on transplant immunity and focus on the potential role of MSCs in protecting islet grafts from both rejection and autoimmune attack.
摘要
间充质干细胞（MSCs）被认为具有抑制免疫反应的能力，并为实现移植耐受提供了治疗潜力。本综述将讨论 MSCs 对移植免疫的影响，并重点探讨 MSCs 在保护胰岛移植物免受排斥和自身免疫攻击方面的潜在作用。
相似文献
1
Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.间质干细胞的免疫抑制能力：胰岛移植中的治疗意义。
Transplantation. 2010 Feb 15;89(3):270-3. doi: 10.1097/TP.0b013e3181c6ffbe.
2
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.间充质干细胞通过基质金属蛋白酶-2和-9的免疫抑制活性来防止完全同种异体胰岛移植的排斥反应。
Diabetes. 2009 Aug;58(8):1797-806. doi: 10.2337/db09-0317. Epub 2009 Jun 9.
3
Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.间充质干细胞有助于在大鼠中诱导混合造血嵌合体和胰岛同种异体移植耐受，且不发生移植物抗宿主病。
Am J Transplant. 2007 Feb;7(2):336-46. doi: 10.1111/j.1600-6143.2006.01643.x.
4
Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation.间充质基质细胞作为控制同种异体胰岛移植中病理性 T 细胞反应的一种手段。
Curr Opin Organ Transplant. 2013 Feb;18(1):59-64. doi: 10.1097/MOT.0b013e32835c2adf.
5
Potential of mesenchymal stromal cells for improving islet transplantation outcomes.间充质基质细胞在改善胰岛移植效果方面的潜力。
Curr Opin Pharmacol. 2018 Dec;43:34-39. doi: 10.1016/j.coph.2018.07.011. Epub 2018 Aug 10.
6
Co-transplantation of Xenogeneic Bone Marrow-derived Mesenchymal Stem Cells Alleviates Rejection of Pancreatic Islets in Non-obese Diabetic Mice.异种骨髓来源间充质干细胞共移植减轻非肥胖糖尿病小鼠胰岛的排斥反应
Transplant Proc. 2017 May;49(4):902-905. doi: 10.1016/j.transproceed.2017.01.064.
7
Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.间充质干细胞可预防胰岛移植的急性排斥反应并延长移植物功能。
Diabetes Technol Ther. 2010 Jun;12(6):435-46. doi: 10.1089/dia.2009.0154.
8
Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.脂肪组织来源的间充质干细胞在实验性自身免疫性1型糖尿病同种异体胰岛复合移植中的免疫调节和保护作用
Immunol Lett. 2017 Aug;188:21-31. doi: 10.1016/j.imlet.2017.05.006. Epub 2017 May 12.
9
Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.CD11b(+) 细胞诱导的白细胞介素 (IL)-10 和 IL-10 激活的调节性 T 细胞在大鼠胰岛同种异体移植物中调节间充质干细胞的免疫中发挥作用。
Mol Med. 2011;17(7-8):697-708. doi: 10.2119/molmed.2010.00098. Epub 2011 Feb 25.
10
Islet cell transplantation for insulin-dependent diabetes.胰岛细胞移植治疗胰岛素依赖型糖尿病。
Hosp Pract (1995). 1995 Jun 15;30(6):41-5. doi: 10.1080/21548331.1995.11443212.
引用本文的文献
1
Mechanism of cell death and its application in the repair of inflammatory bowel disease by mesenchymal stem cells.细胞死亡机制及其在间充质干细胞修复炎症性肠病中的应用
Front Immunol. 2025 Jun 4;16:1597462. doi: 10.3389/fimmu.2025.1597462. eCollection 2025.
2
Classes of Stem Cells: From Biology to Engineering.干细胞类别：从生物学到工程学
Regen Eng Transl Med. 2024 Sep;10(3):309-322. doi: 10.1007/s40883-023-00317-x. Epub 2023 Sep 18.
3
Mesenchymal stromal cells protect tissues from Th1 immune responses via IL-11 secretion.间质基质细胞通过分泌白细胞介素-11 来保护组织免受 Th1 免疫应答的影响。
FASEB J. 2024 May 31;38(10):e23683. doi: 10.1096/fj.202400078R.
4
Mesenchymal stem cells: amazing remedies for bone and cartilage defects.间充质干细胞：治疗骨和软骨缺损的神奇方法。
Stem Cell Res Ther. 2020 Nov 23;11(1):492. doi: 10.1186/s13287-020-02001-1.
5
An important step towards a prevascularized islet microencapsulation device: in vivo prevascularization by combination of mesenchymal stem cells on micropatterned membranes.向预血管化胰岛微囊化装置迈出的重要一步：间质干细胞在微图案化膜上的体内预血管化。
J Mater Sci Mater Med. 2018 Nov 9;29(11):174. doi: 10.1007/s10856-018-6178-6.
6
Cell-based liver therapies: past, present and future.基于细胞的肝脏治疗：过去、现在和未来。
Philos Trans R Soc Lond B Biol Sci. 2018 Jul 5;373(1750). doi: 10.1098/rstb.2017.0229.
7
In vitro reprogramming of rat bmMSCs into pancreatic endocrine-like cells.大鼠骨髓间充质干细胞体外重编程为胰腺内分泌样细胞。
In Vitro Cell Dev Biol Anim. 2017 Feb;53(2):157-166. doi: 10.1007/s11626-016-0087-0. Epub 2016 Oct 3.
8
Bioprinting and Differentiation of Stem Cells.干细胞的生物打印与分化
Molecules. 2016 Sep 8;21(9):1188. doi: 10.3390/molecules21091188.
9
Mesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus.间充质基质细胞作为支持1型糖尿病胰岛移植的治疗策略
Cell Med. 2011 Oct 1;2(2):43-53. doi: 10.3727/215517911X593100. eCollection 2011.
10
A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods.间充质干细胞分泌物的治疗效果及不同培养方法对其分泌修饰诱导作用的综述。
J Transl Med. 2014 Oct 11;12:260. doi: 10.1186/s12967-014-0260-8.
本文引用的文献
1
Mesenchymal stem cells: a potential border patrol for transplanted islets?间充质干细胞：移植胰岛的潜在边界巡逻者？
Diabetes. 2009 Aug;58(8):1728-9. doi: 10.2337/db09-0749.
2
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.骨髓间充质干细胞在实验性自身免疫性1型糖尿病中的免疫调节功能
J Immunol. 2009 Jul 15;183(2):993-1004. doi: 10.4049/jimmunol.0900803. Epub 2009 Jun 26.
3
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.间充质干细胞通过基质金属蛋白酶-2和-9的免疫抑制活性来防止完全同种异体胰岛移植的排斥反应。
Diabetes. 2009 Aug;58(8):1797-806. doi: 10.2337/db09-0317. Epub 2009 Jun 9.
4
Donor reactive regulatory T cells.供体反应性调节性T细胞
Curr Opin Organ Transplant. 2009 Aug;14(4):432-8. doi: 10.1097/MOT.0b013e32832c58f1.
5
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.移植前输注间充质干细胞可通过产生调节性T细胞延长半同种异体心脏移植的存活时间。
J Immunol. 2008 Sep 15;181(6):3933-46. doi: 10.4049/jimmunol.181.6.3933.
6
Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.间充质干细胞与低剂量霉酚酸协同作用可诱导对实体器官同种异体移植物的长期接受。
Transpl Immunol. 2008 Nov;20(1-2):55-60. doi: 10.1016/j.trim.2008.08.004. Epub 2008 Aug 30.
7
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.细胞性胰岛自身免疫与胰岛细胞移植的临床结局相关。
PLoS One. 2008 Jun 18;3(6):e2435. doi: 10.1371/journal.pone.0002435.
8
IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.用于治疗和预防移植物抗宿主病的γ干扰素激活间充质干细胞
Eur J Immunol. 2008 Jun;38(6):1745-55. doi: 10.1002/eji.200738129.
9
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.间充质干细胞治疗类固醇难治性重度急性移植物抗宿主病：一项II期研究。
Lancet. 2008 May 10;371(9624):1579-86. doi: 10.1016/S0140-6736(08)60690-X.
10
Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells.自身免疫性糖尿病患者的胰岛移植会诱导产生稳态细胞因子，从而使自身反应性记忆T细胞扩增。
J Clin Invest. 2008 May;118(5):1806-14. doi: 10.1172/JCI35197.
Zotero 插件